These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 19837868

  • 1. Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review.
    Tegethoff M, Pryce C, Meinlschmidt G.
    Endocr Rev; 2009 Dec; 30(7):753-89. PubMed ID: 19837868
    [Abstract] [Full Text] [Related]

  • 2. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk.
    Braun T, Challis JR, Newnham JP, Sloboda DM.
    Endocr Rev; 2013 Dec; 34(6):885-916. PubMed ID: 23970762
    [Abstract] [Full Text] [Related]

  • 3. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids.
    Kapoor A, Petropoulos S, Matthews SG.
    Brain Res Rev; 2008 Mar; 57(2):586-95. PubMed ID: 17716742
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD008727. PubMed ID: 22592733
    [Abstract] [Full Text] [Related]

  • 5. Fetal glucocorticoid exposure and hypothalamo-pituitary-adrenal (HPA) function after birth.
    Matthews SG, Owen D, Kalabis G, Banjanin S, Setiawan EB, Dunn EA, Andrews MH.
    Endocr Res; 2004 Nov 16; 30(4):827-36. PubMed ID: 15666833
    [Abstract] [Full Text] [Related]

  • 6. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.
    Waffarn F, Davis EP.
    Am J Obstet Gynecol; 2012 Dec 16; 207(6):446-54. PubMed ID: 22840973
    [Abstract] [Full Text] [Related]

  • 7. Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs.
    Dean F, Yu C, Lingas RI, Matthews SG.
    Neuroendocrinology; 2001 Mar 16; 73(3):194-202. PubMed ID: 11307038
    [Abstract] [Full Text] [Related]

  • 8. Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration.
    Zhang C, Xu D, Luo H, Lu J, Liu L, Ping J, Wang H.
    Toxicology; 2014 Nov 05; 325():74-84. PubMed ID: 25194749
    [Abstract] [Full Text] [Related]

  • 9. The impact of maternal synthetic glucocorticoid administration in late pregnancy on fetal and early neonatal hypothalamic-pituitary-adrenal axes regulatory genes is dependent upon dose and gestational age at exposure.
    Li S, Moss TJ, Nitsos I, Matthews SG, Challis JR, Newnham JP, Sloboda DM.
    J Dev Orig Health Dis; 2013 Feb 05; 4(1):77-89. PubMed ID: 25080184
    [Abstract] [Full Text] [Related]

  • 10. Sex differences in early-life programming of the hypothalamic-pituitary-adrenal axis in humans suggest increased vulnerability in females: a systematic review.
    Carpenter T, Grecian SM, Reynolds RM.
    J Dev Orig Health Dis; 2017 Apr 05; 8(2):244-255. PubMed ID: 28103963
    [Abstract] [Full Text] [Related]

  • 11. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs.
    Banjanin S, Kapoor A, Matthews SG.
    J Physiol; 2004 Jul 01; 558(Pt 1):305-18. PubMed ID: 15146051
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS, Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ.
    Cochrane Database Syst Rev; 2015 Aug 17; (8):CD008727. PubMed ID: 26282194
    [Abstract] [Full Text] [Related]

  • 13. The fetal and neonatal hypothalamic-pituitary-adrenal axis.
    Ng PC.
    Arch Dis Child Fetal Neonatal Ed; 2000 May 17; 82(3):F250-4. PubMed ID: 10794797
    [No Abstract] [Full Text] [Related]

  • 14. [Steroid therapy and adrenal function].
    Cota D, Ceroni L, Pasquali R.
    Recenti Prog Med; 2000 Nov 17; 91(11):594-600. PubMed ID: 11125954
    [Abstract] [Full Text] [Related]

  • 15. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome.
    Weinberg J, Sliwowska JH, Lan N, Hellemans KG.
    J Neuroendocrinol; 2008 Apr 17; 20(4):470-88. PubMed ID: 18266938
    [Abstract] [Full Text] [Related]

  • 16. Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function.
    Iqbal M, Moisiadis VG, Kostaki A, Matthews SG.
    Endocrinology; 2012 Jul 17; 153(7):3295-307. PubMed ID: 22564976
    [Abstract] [Full Text] [Related]

  • 17. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice.
    Liang G, Chen M, Pan XL, Zheng J, Wang H.
    Exp Toxicol Pathol; 2011 Nov 17; 63(7-8):607-11. PubMed ID: 20627497
    [Abstract] [Full Text] [Related]

  • 18. Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes.
    Duthie L, Reynolds RM.
    Neuroendocrinology; 2013 Nov 17; 98(2):106-15. PubMed ID: 23969897
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids and fetal programming part 1: Outcomes.
    Moisiadis VG, Matthews SG.
    Nat Rev Endocrinol; 2014 Jul 17; 10(7):391-402. PubMed ID: 24863382
    [Abstract] [Full Text] [Related]

  • 20. Prenatal bisphenol a exposure and dysregulation of infant hypothalamic-pituitary-adrenal axis function: findings from the APrON cohort study.
    Giesbrecht GF, Ejaredar M, Liu J, Thomas J, Letourneau N, Campbell T, Martin JW, Dewey D, APrON Study Team.
    Environ Health; 2017 May 19; 16(1):47. PubMed ID: 28526030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.